APA (7th ed.) Citation

Leong, D. P., Caron, F., Hillis, C., Duan, A., Healey, J. S., Fraser, G., & Siegal, D. (2016). The risk of atrial fibrillation with ibrutinib use: A systematic review and meta-analysis. Blood, 128(1), 138-140. https://doi.org/10.1182/blood-2016-05-712828

Chicago Style (17th ed.) Citation

Leong, Darryl P., François Caron, Christopher Hillis, Annie Duan, Jeff S. Healey, Graeme Fraser, and Deborah Siegal. "The Risk of Atrial Fibrillation with Ibrutinib Use: A Systematic Review and Meta-analysis." Blood 128, no. 1 (2016): 138-140. https://doi.org/10.1182/blood-2016-05-712828.

MLA (9th ed.) Citation

Leong, Darryl P., et al. "The Risk of Atrial Fibrillation with Ibrutinib Use: A Systematic Review and Meta-analysis." Blood, vol. 128, no. 1, 2016, pp. 138-140, https://doi.org/10.1182/blood-2016-05-712828.